Table 3.
Changes in metabolic and inflammatory biomarker outcomes in mindfulness and standard group
| Mean Change from Baseline (± SD)1 | |||
|---|---|---|---|
| Mindfulness Group (n=9) |
Standard Group (n=9) |
P-value2 | |
| Metabolic Biomarkers | |||
| HbA1C (%) | |||
| 12 weeks | 0.27 ± 0.70 | −0.12 ± 0.20 | 0.073 |
| 6 months | 0.34 ± 0.38 | −0.06 ± 0.31 | 0.03 |
| Adiponectnin (ug/mL) | |||
| 12 weeks | −0.10 ± 1.50 | 0.06 ± 0.69 | 0.78 |
| 6 months | −0.13 ± 1.68 | −0.35 ± 0.67 | 0.73 |
| Inflammatory Biomarkers | |||
| Hs-CRP (mg/L) | |||
| 12 weeks | 0.17 ± 2.80 | 0.09 ± 0.89 | 0.743 |
| 6 months | 0.12 ± 1.37 | 0.26 ± 0.57 | 0.79 |
| IL-6 (pg/ml) | |||
| 12 weeks | 0.70 ± 2.86 | −1.17 ± 5.47 | 0.673 |
| 6 months | 0.26 ± 1.61 | −1.08 ± 6.47 | 0.493 |
| TNF-a (pg/mL) | |||
| 12 weeks | 0.12 ± 0.22 | −0.06 ± 0.29 | 0.16 |
| 6 months | −0.02 ± 0.34 | 0.09 ± 0.38 | 0.52 |
Mean changes from baseline calculated as ‘12 week-Baseline’ and ‘6 month-Baseline’.
P-values for between-group differences calculated using t-tests for normally distributed differences and the Wilcoxon rank sum test for non-normally distributed differences.
Indicates p-value calculated using Wilcoxon-rank sum test. All others calculated using t-test.